| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0005 |